BINDING OF ORAL-CONTRACEPTIVE PROGESTOGENS TO SERUM-PROTEINS AND CYTOPLASMIC-RECEPTOR

被引:41
作者
JUCHEM, M [1 ]
POLLOW, K [1 ]
机构
[1] UNIV MAINZ, DEPT EXPTL ENDOCRINOL, LANGENBECKSTR 1, W-6500 MAINZ 1, GERMANY
关键词
SEX HORMONE BINDING GLOBULIN; COMPETITION STUDIES; STEROID RECEPTORS; GESTODENE; DESOGESTREL; LEVONORGESTREL; NORGESTIMATE;
D O I
10.1016/0002-9378(90)90559-P
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Some progestogens widely used in oral contraceptives are characterized at the level of high-affinity receptor binding as well as binding to sex hormone-binding globulin and corticosteroid-binding globulin. With regard to binding to sex hormone-binding globulin, gestodene, levonorgestrel, and to a lesser extent 3-ketodesogestrel (which is only formed from the prodrug desogestrel in the body), show a behavior that is manifested in the relatively high affinity to sex hormone-binding globulin, whereas desogestrel and norgestimate do not display any measurable affinity for this specific steroid-binding serum protein. Furthermore, levonorgestrel and gestodene dissociate very much more slowly from the binding sites of sex hormone-binding globulin than 3-ketodesogestrel. A natural affinity of all these synthetic progestogens tested for corticosteroid-binding globulin could not be established. Gestodene, levonorgestrel, and 3-ketodesogestrel bind to the progesterone, glucocorticoid, and androgen receptor with high affinity, apart from slight differences, whereas estrogen receptor affinity could not be demonstrated in any of the progestogens investigated. In relation to aldosterone, the relative binding affinity values of gestodene, levonorgestrel, and the natural progestogen progesterone are relatively high, whereas 3-ketodesogestrel does not display any measurable affinity for this receptor species.
引用
收藏
页码:2171 / 2183
页数:13
相关论文
共 34 条
[1]  
[Anonymous], ARCH ANAT MICR MORPH
[2]  
BEIER S, 1986, RES REPORTS GYNECOLO, P477
[3]   BINDING OF A CONTRACEPTIVE PROGESTOGEN ORG-2969 AND ITS METABOLITES TO RECEPTOR PROTEINS AND HUMAN SEX-HORMONE BINDING GLOBULIN [J].
BERGINK, EW ;
HAMBURGER, AD ;
DEJAGER, E ;
VANDERVIES, J .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1981, 14 (02) :175-183
[4]   EFFECTS OF ORAL-CONTRACEPTIVE COMBINATIONS CONTAINING LEVONORGESTREL OR DESOGESTREL ON SERUM-PROTEINS AND ANDROGEN BINDING [J].
BERGINK, EW ;
HOLMA, P ;
PYORALA, T .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 (07) :663-668
[5]  
BERGINK EW, 1983, ORAL CONTRACEPTIVES, P52
[6]  
DJERASSI C, 1954, J AM CHEM SOC, V76, P4472
[7]  
ELGER W, 1966, ARCH ANAT MICROSC MO, V55, P657
[8]  
ELMAKHZANGY MN, 1979, CLIN ENDOCRINOL, V10, P39
[9]  
GASPARD UJ, 1983, ROLE ANTIANDROGENS T, P369
[10]   PHARMACOLOGICAL PROFILE OF NORGESTIMATE, A NEW ORALLY ACTIVE PROGESTIN [J].
HAHN, DW ;
ALLEN, GO ;
MCGUIRE, JL .
CONTRACEPTION, 1977, 16 (05) :541-553